Eijkelkamp N, Kavelaars A, Elsenbruch S, Schedlowski M, Holtmann G, Heijnen CJ. Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol 293: G749-G757, 2007. First published July 26, 2007; doi:10.1152/ajpgi.00114.2007.-During acute and chronic inflammation visceral pain perception is altered. Conflicting data exist, however, on visceral pain perception in the postinflammatory phase. The aim of the present study was to investigate whether visceral pain perception is altered after resolution of dextran sodium sulfate (DSS)-induced inflammation of the colon. Visceral sensory function in mice was assessed by monitoring behavioral responses to intracolonic capsaicin instillation. Two hours later the number of c-Fos-positive neurons in lamina I/II and X of spinal cord segments T12/13-S1 was determined as a measure of neuronal activation. DSS colitis was induced by adding 1% of DSS to the drinking water. The course of DSS-induced colitis was assessed by determining the disease activity index score. Animals developed a transient colitis and had recovered at day 49. At this time point, cytokine levels and colon length were similar to control animals. Importantly, after resolution of DSS-induced colitis the behavioral response to intracolonic capsaicin was increased compared with control mice. Moreover, capsaicin-induced spinal cord neuronal c-Fos expression was significantly increased. Interestingly, after colitis animals also exhibited referred somatic hyperalgesia as measured with von Frey hairs on the abdominal wall. We conclude that postinflammatory visceral hyperalgesia occurs after resolution of DSS-induced colitis and that capsaicin-induced behavioral responses and spinal cord neuronal c-Fos activation are effective readouts for determination of visceral pain perception. visceral hyperalgesia; dextran sodium sulfate-induced colitis; referred hyperalgesia; inflammation VISCERAL PAIN IS AN IMPORTANT disease symptom in patients with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD) (8). Moreover, it has been described that patients with IBS have a decreased threshold for rectal distension (2, 9, 25). However, studies on the threshold for pain in IBD patients are conflicting. Both increases as well as decreases in the sensitivity to rectal distension have been observed in IBD patients (2, 9, 13). Mediators such as bradykinin, serotonin, adenosine 5Ј-triphosphate (ATP), PGE 2 , the chemokine (C-C motif) ligand 3 (CCL3), interleukin-1 (IL-1), and epinephrine, which are secreted during acute inflammation of the colon by either immune or nonimmune cells, are thought to directly sensitize neuronal afferents leading to visceral hyperalgesia (4,5,7, 21). Indeed, during acute mucosal inflammation induced in rodents by colorectal instillation of chemical irritants such as zymosan, acetic acid, trinitrobenzene sulfonic acid (TNBS), or turpentine, visceral hypersensitivity to painful stimuli can be detected ...